Italy Coronary Stents Market Report 2022 to 2030

Italy Coronary Stents Market Analysis

$ 3999

Italy's Coronary Stents Market is expected to witness growth from $271 Mn in 2022 to $378 Mn in 2030 with a CAGR of 4.25% for the forecasted year 2022-2030. Italy's growing elderly population and high prevalence of risk factors like smoking, hypertension, and diabetes are contributing to an increase in the incidence of coronary artery disease. Because of this, there is a rising need for coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Sorin Group, Invatec, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

ID: IN10ITMD006 CATEGORY: Medical Devices GEOGRAPHY: Italy AUTHOR: Jigyasu Bhandari

Buy Now

Italy Coronary Stents Healthcare Market Executive Analysis

Italy's Coronary Stents Market is expected to witness growth from $271 Mn in 2022 to $378 Mn in 2030 with a CAGR of 4.25% for the forecasted year 2022-2030. In Italy, The National Health System expenses that the State finances are given a recurring total resource amount under the Italian Finance Act. Throughout the 2022 Finance Act, the National Health Fund will receive $2.11 billion more in funding, bringing its total from $128.73 billion to $130.84 billion in 2022, $132.95 billion in 2023, and $135.06 billion in 2024. In 2022, 2023, and 2024, respectively, an additional $105.52 million, $211.04 million, and $316.56 million will be added to the budget designated for the procurement of innovative pharmaceuticals.

In 2022, Italy had an age-standardized incidence rate of 38.9 per 100,000 person-years for acute myocardial infarction. Around 20% of all deaths in Italy are caused by coronary artery disease, making it a major cause of death. Italy experienced 54,505 fatalities from ischemic heart disease, which includes CAD, in 2022. Coronary stents are utilized to open up the restricted or obstructed arteries in order to restore blood flow to the heart. This can aid in the relief of symptoms including shortness of breath and chest pain. A small incision in the groin or wrist is required for the minimally invasive technique of placing a coronary stent, which includes threading a catheter into the artery to the blocked or narrowed location. This indicates that compared to open heart surgery, the operation is less intrusive and requires a quicker recovery. Patients with CAD may experience long-term advantages from coronary stents because they keep the arteries open and lower the chance of further blockages or constriction. This may lessen the need for additional procedures or interventions.

Italy Coronary Stents Market Analysis

Market Dynamics

Market Growth Drivers

Italy's growing elderly population and high prevalence of risk factors like smoking, hypertension, and diabetes are contributing to an increase in the incidence of coronary artery disease. Because of this, there is a rising need for coronary stents. Newer and more advanced coronary stents that give better results and lower risk of complications have been introduced as a result of the development of new technologies and materials. This has aided in boosting demand for these more recent stents, particularly among patients looking for the best possible treatments. The use of coronary stents is one minimally invasive therapy that is rising in popularity in Italy since it has a number of benefits over open heart surgery. These benefits, which include quicker healing times, less discomfort, and a lower chance of problems, have helped increase demand for coronary stents.

Market Restraints

In Italy, manufacturers may experience price pressure as they attempt to preserve or grow their market position in the fiercely competitive Italian coronary stent industry. This can be difficult since healthcare providers could be unwilling to shell out top dollar for brand-new or cutting-edge coronary stents. Aside from medicine and lifestyle changes, there are other options for treating coronary artery disease besides coronary stents. These options may be more appealing to some patients, which may reduce the need for coronary stents.

Competitive Landscape

Key Players

Sorin Group (IT)
Invatec (IT)
Biotronik
Boston Scientific
B. Braun
Abbott Laboratories
GE Healthcare
Medtronic
Philipps Healthcare

Healthcare Policies and Regulatory Landscape

In Italy, a new regulation known as the European Medical Devices Regulation (EU MDR) replaced the old Medical Devices Directive (MDD) in May 2021. In order to guarantee the effectiveness and safety of their products, the regulation establishes new guidelines for medical device producers. All medical devices sold in the European Union, including coronary stents, are covered by the EU MDR. Italy's public healthcare system is known as National Health Service SSN. All Italian citizens are covered by the system, which also covers the cost of medical devices like coronary stents. Medical device reimbursement regulations, however, can be intricate and regionally specific. The regulatory organisation in charge of licencing medicines and medical devices in Italy is called the Italian Medicines Agency (AIFA). Before approving medical devices for sale in Italy, the government evaluates their quality, safety, and efficacy.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cItlayity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.